Last reviewed · How we verify

NCT05670249: DEMCI

Decompressive Craniectomy in Patients With Cerebellar Infarction

Completed NA Last updated 4 January 2023
What this trial tests

NA trial testing suboccipital decompressive craniectomy in Cerebellar Stroke in 72 participants. Completed in 30 April 2021.

Timeline
5 January 2016
Primary endpoint
25 December 2019
30 April 2021

Quick facts

Lead sponsorEge University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposeprevention
Enrollment72
Start date5 January 2016
Primary completion25 December 2019
Estimated completion30 April 2021

Drugs / interventions tested

Conditions studied

Sponsor

Ege University

Who can join

Adults 40 to 80, any sex, with Cerebellar Stroke. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The investigators aimed to evaluate the outcome in participants up to 80 years of age with space-occupying cerebellar infarction treated with suboccipital decompressive craniectomy (SDC) compared to medical therapy alone.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Ege University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05670249.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing